EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment

Mingyang Jiang, Ke Zhang, Zhenwang Zhang, Xinran Zeng, Zihang Huang, Peizhuo Qin, Zhilin Xie, Xue Cai, Milad Ashrafizadeh, Yu Tian, Ruqiong Wei

MedComm · 2025-08 · 6 (8)

DOI: 10.1002/mco2.70295 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 30.07.2025. Verfasst von Mingyang Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Joint Surgery The First Affiliated Hospital of Guangxi Medical University Nanning China. Die Arbeit wurde bisher 179-mal zitiert (Crossref) und nennt 327 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The PI3K/AKT/mTOR signaling axis is a pivotal regulator of key cellular functions, including proliferation, metabolism, survival, and immune modulation. In cancer, its dysregulation drives malignant transformation, tumor progression, therapeutic resistance, and immune evasion. Despite numerous studies, an integrated understanding of this pathway's multifaceted role in tumor biology and treatment remains incomplete. This review comprehensively outlines the oncogenic mechanisms governed by the PI3K/AKT/mTOR pathway, including its regulation of epithelial–mesenchymal transition, autophagy, apoptosis, glycolysis, ferroptosis, and lipid metabolism. We emphasize the dual role of autophagy, its interplay with therapeutic resistance, and its contextual impact on cancer dynamics. Moreover, we explore the epigenetic regulation of this axis by noncoding RNAs (miRNAs, lncRNAs, circRNAs) and its influence on tumor hallmarks. The review also highlights the pathway's involvement in modulating responses to chemotherapy, radiotherapy, and immunotherapy, as well as its role in remodeling the tumor microenvironment. We critically evaluate emerging therapeutic strategies targeting the PI3K/AKT/mTOR axis, including small‐molecule inhibitors, phytochemicals, and nanoparticle‐based systems. By elucidating the integrated landscape of this pathway, our review highlights its value as a central therapeutic target and offers insights into precision oncology approaches aimed at overcoming drug resistance and enhancing treatment efficacy.

Schlagwörter

Stichwörter der Autor:innen

PI3K/AKT/mTOR axiscancer therapychemotherapy and immunotherapydrug deliverymolecular pathway

Autor:innen und Institutionen

  • Department of Bone and Joint Surgery The First Affiliated Hospital of Guangxi Medical University Nanning China.
  • Hubei Key Laboratory of Diabetes and Angiopathy School of Pharmacy Xianning Medical College Hubei University of Science and Technology Xianning Hubei Province China.
  • Guangxi Medical University Nanning China.
  • Department of Psychosomatic Medicine The Huizhou Second People's Hospital Guangdong China.
  • Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan Shand…
  • Research Center the Huizhou Central People's Hospital Guangdong Medical University Huizhou Guangdong China.

Zitieren

APA

Jiang, M., Zhang, K., Zhang, Z., Zeng, X., Huang, Z., Qin, P., Xie, Z., Cai, X., Ashrafizadeh, M., Tian, Y., & Wei, R. (2025). PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. MedComm, 6(8). https://doi.org/10.1002/mco2.70295

Vancouver

Jiang M, Zhang K, Zhang Z, Zeng X, Huang Z, Qin P, et al. PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. MedComm. 2025;6(8). doi:10.1002/mco2.70295

BibTeX
@article{Jiang2025,
  author = {Jiang, Mingyang and Zhang, Ke and Zhang, Zhenwang and Zeng, Xinran and Huang, Zihang and Qin, Peizhuo and Xie, Zhilin and Cai, Xue and Ashrafizadeh, Milad and Tian, Yu and Wei, Ruqiong},
  title = {PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment},
  journal = {MedComm},
  year = {2025},
  volume = {6},
  number = {8},
  doi = {10.1002/mco2.70295}
}
Kostenlos starten →